iANTHUS CAPITAL HOLDINGS (ITHUF) Gains from Investment Securities (2021 - 2026)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Gains from Investment Securities came in at -$910000.0 in Q1 2026, up 11.56% year-on-year from -$815670.7 in Q1 2025, and down 611.24% quarter-over-quarter from $178000.0 in Q4 2025.
iANTHUS CAPITAL HOLDINGS (ITHUF) Gains from Investment Securities (2021 - 2026) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed Gains from Investment Securities across 6 years of filings, most recently posting -$910000.0 for Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at -$910000.0, up 11.56% year-over-year; the trailing twelve-month figure through Mar 2026 was -$910000.0 (up 11.56% YoY), and the FY2025 annual result was $155254.0, down 98.03% from the prior year.
- Gains from Investment Securities came in at -$910000.0 for Q1 2026 at iANTHUS CAPITAL HOLDINGS, down from $178000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $7.9 million in Q2 2025 to a low of -$6.4 million in Q3 2024.
- The 5-year median for Gains from Investment Securities is -$292000.0 (2022), against an average of -$744491.6.
- Across the five-year window, Gains from Investment Securities slumped 1244.28% in 2024 and jumped 4962.35% in 2025, its largest moves.
- iANTHUS CAPITAL HOLDINGS's Gains from Investment Securities stood at -$422000.0 in 2022, then soared by 173.93% to $312000.0 in 2023, then tumbled by 53.21% to $146000.0 in 2024, then grew by 21.92% to $178000.0 in 2025, then tumbled by 611.24% to -$910000.0 in 2026.
- The last three Gains from Investment Securities figures came in at -$910000.0 (Q1 2026), $178000.0 (Q4 2025), and $30117.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -910,000.00 |
| Mar 31, 2026 | -910,000.00 |
| Dec 31, 2025 | 178,000.00 |
| Dec 31, 2025 | 178,000.00 |
| Sep 30, 2025 | 30,117.00 |
| Sep 30, 2025 | 30,117.00 |
| Jun 30, 2025 | 7.88 Mn |
| Jun 30, 2025 | 7.88 Mn |
| Mar 31, 2025 | -1.03 Mn |
| Mar 31, 2025 | -1.03 Mn |
| Dec 31, 2024 | 146,000.00 |
| Dec 31, 2024 | 146,000.00 |
| Sep 30, 2024 | -6.42 Mn |
| Sep 30, 2024 | -6.42 Mn |
| Jun 30, 2024 | -162,000.00 |
| Jun 30, 2024 | -162,000.00 |
| Mar 31, 2024 | -2.30 Mn |
| Mar 31, 2024 | -2.30 Mn |
| Dec 31, 2023 | 312,000.00 |
| Dec 31, 2023 | 312,000.00 |